Ingber A, Cohen Y, Krimsky M, Yedgar S. A novel treatment of contact dermatitis by topical application of phospholipase A2 inhibitor: a double-blind placebo-controlled pilot study. Int J Immunopathol Pharmacol. 2007 Jan-Mar;20(1):191-5.

Yedgar S, Krimsky M, Cohen Y, Flower RJ. Treatment of inflammatory diseases by selective eicosanoid inhibition: a double-edged sword? Trends Pharmacol Sci. 2007 Sep;28(9):459-64. Epub 2007 Aug 10. Review.

Yedgar S, Cohen Y, Shoseyov D. Control of phospholipase A2 activities for the treatment of inflammatory conditions. Biochim Biophys Acta. 2006 Nov;1761(11):1373-82. Epub 2006 Aug 3. Review.

Beck GCh, Hermes WC, Yard BA, Kaszkin M, von Zabern D, Schulte J, Haak M, Prem K, Krimsky W, van Ackern K, van der Woude FJ, Yedgar S. Amelioration of endotoxin-induced sepsis in rats by membrane anchored lipid conjugates. Crit Care Med. 2003 Jul;31(7):2015-21.

Chen WM, Soria J, Soria C, Krimsky M, Yedgar S. Control of capillary formation by membrane-anchored extracellular inhibitor of phospholipase A(2). FEBS Lett. 2002 Jul 3;522(1-3):113-8.

Shoseyov D, Bibi H, Offer S, Schwob O, Krimsky M, Kleiman M, Yedgar S. Treatment of ovalbumin-induced experimental allergic bronchitis in rats by inhaled inhibitor of secretory phospholipase A(2). Thorax. 2005 Sep;60(9):747-53. Epub 2005 Jun 30.

Krimsky M, Yedgar S, Aptekar L, Schwob O, Goshen G, Gruzman A, Sasson S, Ligumsky M. Amelioration of TNBS-induced colon inflammation in rats by phospholipase A2 inhibitor. Am J Physiol Gastrointest Liver Physiol. 2003 Sep;285(3):G586-92. Epub 2003 Apr 30.